Robot-Enhanced Stroke Therapy Optimizes Rehabilitation (RESTORE) (RESTORE)
Stroke

About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Stroke Rehabilitation, Robotic Exoskeleton
Eligibility Criteria
Inclusion Criteria:
- Recent first stroke (ischemic or hemorrhagic)
- Upper extremity Fugl-Meyer score 15-45
- Modified Ashworth score of shoulder/elbow less than or equal to 2
- Able to follow task instructions
- Visual acuity better than 20/50 in both eyes
- Able to give consent
- Able to commit to follow-up
Exclusion Criteria:
- Prior stroke or significant neurologic problem (e.g. Multiple Sclerosis)
- Pre-existing musculoskeletal injury that will interfere with active therapy
- Pre-Stroke Modified Rankin Score > 2
- Clinical evidence of Unilateral Spatial Neglect on the Behavioural Inattention Test (BIT)
- Enrollment in a concurrent clinical intervention trial
- Major co-morbid or concurrent illness such that improvement is unlikely or completion of the protocol as specified is unlikely
Sites / Locations
- Foothills HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Early Robotic Rehab Low Intensity
Early Robotic Rehab High Intensity
Late Robotic Rehab Low Intensity
Late Robotic Rehab High Intensity
Control Group
This group will begin robotic rehabilitation using a robotic exoskeleton between days 5-9 after their stroke. They will receive one hour of treatment per day for 20 days.
This group will begin robotic rehabilitation using a robotic exoskeleton between days 5-9 after their stroke. They will receive 2 one-hour treatment sessions per day for 20 days.
This group will begin robotic rehabilitation using a robotic exoskeleton between days 21-25 after their stroke. They will receive one hour of treatment per day for 20 days.
This group will begin robotic rehabilitation using a robotic exoskeleton between days 21-25 after their stroke. They will receive 2 one-hour treatment sessions per day for 20 days.
This group will receive usual care with robotic assessment.